EVOLENT HEALTH INC - NOTE 1.500%10/1

Historical Holders from Q4 2019 to Q3 2025

Type / Class
Debt / NOTE 1.500%10/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
4,500,000
Holdings value
$4,463,668
% of all portfolios
0%
Number of holders
7
Number of buys
1
Number of sells
-5
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of EVOLENT HEALTH INC - NOTE 1.500%10/1

Period Principal Value Change Price Investors
2025 Q3 4,500,000 $4,463,668 -$167,578,453 $0.9931 7
2025 Q2 173,633,000 $171,973,796 +$113,208 $0.9852 10
2025 Q1 173,682,000 $170,808,890 +$1,915,041 $0.9773 9
2024 Q4 171,719,000 $167,318,058 -$12,154,486 $0.9688 9
2024 Q3 182,962,000 $193,561,523 -$526,399 $1.05 14
2024 Q2 181,685,500 $181,195,280 +$981,942 $0.9688 14
2024 Q1 180,676,500 $209,850,274 +$13,173,199 $1.14 10
2023 Q4 169,263,851 $196,559,962 +$5,230,022 $1.14 12
2023 Q3 166,587,063 $179,342,224 +$3,299,805 $1.07 14
2023 Q2 162,822,732 $187,025,288 -$7,530,934 $1.14 18
2023 Q1 167,398,674 $200,614,787 -$6,527,176 $1.19 16
2022 Q4 177,270,000 $192,085,833 -$6,295,655 $1.08 23
2022 Q3 161,533,061 $203,978,640 -$1,825,000 $1.26 23
2022 Q2 164,442,261 $186,382,974 -$7,254,023 $1.13 22
2022 Q1 169,093,061 $208,322,169 +$6,285,511 $1.18 23
2021 Q4 158,664,761 $173,507,093 -$4,442,236 $1.09 21
2021 Q3 162,114,761 $185,920,476 +$11,459,344 $1.15 23
2021 Q2 155,842,126 $150,049,654 -$8,438,383 $0.9652 21
2021 Q1 164,752,126 $154,692,331 -$3,977,127 $0.9406 23
2020 Q4 172,112,000 $147,174,089 +$11,566,638 $0.8587 21
2020 Q3 160,440,000 $125,624,189 +$64,763 $0.7852 17
2020 Q2 154,989,000 $102,819,113 -$5,801,384 $0.6336 19
2020 Q1 164,203,000 $107,710,360 +$5,522,069 $0.6316 20
2019 Q4 163,038,000 $117,284,007 +$117,284,007 $0.6975 20